{"url":"https://lda.senate.gov/api/v1/filings/2abeff8a-fa25-4a8a-96be-5d3e9d0b66bb/","filing_uuid":"2abeff8a-fa25-4a8a-96be-5d3e9d0b66bb","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2013,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2abeff8a-fa25-4a8a-96be-5d3e9d0b66bb/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kimberley Fritts, CEO","dt_posted":"2013-04-22T16:08:46.810000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 G STREET, NW","registrant_address_2":"SUITE 1000 WEST","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":31680,"url":"https://lda.senate.gov/api/v1/registrants/31680/","house_registrant_id":31110,"name":"PODESTA GROUP, INC.","description":"Public policy, government relations and public affairs firm","address_1":"1001 G Street, NW","address_2":"Suite 1000 West","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY PODESTA","contact_telephone":"+1 202-413-5027","dt_updated":"2022-04-06T16:07:38.635383-04:00"},"client":{"id":138663,"url":"https://lda.senate.gov/api/v1/clients/138663/","client_id":1006296,"name":"LIVESTRONG","general_description":"Healthcare foundation","client_government_entity":false,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Healthcare systems and non-communicable disease funding.\nImpact of sequestration on cancer research and patient care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49105,"prefix":"mr","prefix_display":"MR.","first_name":"ARANTHAN","nickname":"AJ","middle_name":null,"last_name":"JONES","suffix":"ii","suffix_display":"II"},"covered_position":null,"new":false},{"lobbyist":{"id":57830,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"CHANG","suffix":null,"suffix_display":null},"covered_position":"Dir. Press & Comm., Nat'l Security Staff","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"Healthcare systems and non-communicable disease funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49105,"prefix":"mr","prefix_display":"MR.","first_name":"ARANTHAN","nickname":"AJ","middle_name":null,"last_name":"JONES","suffix":"ii","suffix_display":"II"},"covered_position":null,"new":false},{"lobbyist":{"id":57830,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"CHANG","suffix":null,"suffix_display":null},"covered_position":"Dir. Press & Comm., Nat'l Security Staff","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Impact of sequestration on cancer research and patient care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49105,"prefix":"mr","prefix_display":"MR.","first_name":"ARANTHAN","nickname":"AJ","middle_name":null,"last_name":"JONES","suffix":"ii","suffix_display":"II"},"covered_position":null,"new":false},{"lobbyist":{"id":57830,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"CHANG","suffix":null,"suffix_display":null},"covered_position":"Dir. Press & Comm., Nat'l Security Staff","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Healthcare systems and non-communicable disease funding.\nImpact of sequestration on cancer research and patient care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49105,"prefix":"mr","prefix_display":"MR.","first_name":"ARANTHAN","nickname":"AJ","middle_name":null,"last_name":"JONES","suffix":"ii","suffix_display":"II"},"covered_position":null,"new":false},{"lobbyist":{"id":57830,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"CHANG","suffix":null,"suffix_display":null},"covered_position":"Dir. Press & Comm., Nat'l Security Staff","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}